Noel Hillier Smith

Title: The Innovations of Noel Hillier Smith

Introduction

Noel Hillier Smith is a prominent inventor based in Cambridge, GB. He has made significant contributions to the field of biotechnology, particularly in the development of CRISPR-associated proteins. His work focuses on enhancing the efficacy of gene editing technologies while minimizing potential immune responses.

Latest Patents

Noel Hillier Smith holds a patent for "CRISPR-associated (Cas) proteins with reduced immunogenicity." This invention relates to methods of reducing the immunogenicity of CRISPR-associated proteins and the modified Cas proteins produced from these methods. The patent also encompasses techniques for cell and gene therapy, including genetic modifications and alterations of gene expression made in-vivo or ex-vivo using these modified Cas proteins.

Career Highlights

Throughout his career, Noel has been associated with Lonza Inc., a leading global provider of integrated healthcare solutions. His work at Lonza has allowed him to push the boundaries of genetic engineering and contribute to advancements in therapeutic applications.

Collaborations

Noel has collaborated with notable colleagues such as Thomas Payne and Jesús Zurdo. These partnerships have fostered innovation and have been instrumental in the development of his patented technologies.

Conclusion

Noel Hillier Smith's contributions to the field of biotechnology, particularly through his patent on CRISPR-associated proteins, highlight his role as a key innovator in genetic engineering. His work continues to pave the way for advancements in gene therapy and related applications.